Bergen, Elisabeth S.
Pilla, Lorenzo
Auclin, Edouard
Ilhan-Mutlu, Aysegül
Prager, Gerald W.
Pietrantonio, Filippo
Antista, Maria
Ghelardi, Filippo
Basile, Debora
Aprile, Giuseppe
Longarini, Raffaella
Hautefeuille, Vincent
Tougeron, David
Artru, Pascal
Mabro, May
Drouillard, Antoine
Roth, Gael
Ben Abdelghani, Meher
Clement, Inès
Toullec, Clemence
Mineur, Laurent
Guimbaud, Rosine
Taieb, Julien
Zaanan, Aziz
Article History
Received: 6 December 2022
Accepted: 14 February 2023
First Online: 7 March 2023
Declarations
:
: EA has participated in advisory boards for Amgen and Sanofi Genzymes. AIM has participated in advisory boards organized by MSD, Servier, and BMS; recived lecture honoraria from Eli Lilly, Servier, BMS, and MSD; is a local PI for clinical trials sponsored by BMS and Roche; declares a consulting role for Astellas and MSD; and received travel support from BMS, Roche, Eli Lilly, and Daiichi Sankyo. GWP declares advisory roles for Merck, Amgen, Roche, Servier, Bayer, Pierre Fabre, MSD, BMS, AstraZeneca, and Daiichi Sankyo. FP has received honoraria as a speaker or in an advisory role from ASTRAZENECA, BMS, MSD, MERCK-SERONO, AMGEN, PIERRE FABRE, LILLY, and SERVIER and received research grants from Astrazeneca, Incyte, and BMS. DT has participated in consulting and/or advisory boards for Amgen, Merck, Roche, Sanofi, Servier, Pierre Fabre, MSD, BMS, Astra Zeneca, and Daiichi Sankyo. PA declares consulting or advisory roles for Servier, Pierre-Fabre, AstraZeneca, BMS, MSD, Amgen, Viatris travel and accommodations or expenses from Servier, Pierre-Fabre. AD has participated in advisory boards for Amgen, Roche, Servier, and AstraZeneca. GR declares consulting or an advisory role for Servier, AstraZeneca, Bristol Myers Squibb, MSD, Servier, Amgen, Ipsen, Viatris, Accord Healthcare, Sanofi and travel, accommodations or expenses from Servier, AstraZeneca, Bristol Myers Squibb, MSD, Roche, Amgen, Ipsen. MBA participated in advisory boards for Merck Serono, BMS, Incyte, Amgen, Pierre Fabre, Servier, Sanofi, IPSEN, and Bayer. CT participated in consulting and/or advisory boards for Amgen, Astra-Zeneca, Bayer, BMS, Ipsen, Merck, MSD, Pierre Fabre, Sanofi, and Servier. RG has received honoraria as a speaker or in an advisory role from AAA, AMGEN, BMS, IPSEN, MSD, PIERRE FABRE, ROCHE, and SERVIER. JT has received honoraria as a speaker or in an advisory role from AMGEN, ASTELLAS, BMS, MSD, MERCK, NOVARTIS, PIERRE FABRE, ROCHE, and SERVIER. AZ has participated in consulting and/or advisory boards for Amgen, Merck, Roche, Sanofi, Servier, Baxter, Havas Life, Alira Health, Zymeworks, MSD, BMS, AstraZeneka, Daiichi Sankyo. All other authors declare no conflicts of interests.Ethical approval and consent to participate.This study was conducted in accordance with the Declaration of Helsinki and approval by each national institutional review board (IRB) was obtained.
: Not applicable.
Free to read: This content has been made available to all.